Antibiotic resistance of Helicobacter pylori strains in Japanese children

Journal of Clinical Microbiology

Volumn 40, Issue 2, 2002, Pages 649-653

  Kato, Seiichi ^a   Fujimura, Shigeru ^a   Udagawa, Hirokazu ^a   Shimizu, Toshiaki ^a   Maisawa, Shunichi ^a   Ozawa, Kyoko ^a   Iinuma, Kazuie ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CLARITHROMYCIN; METRONIDAZOLE; MINOCYCLINE; RNA 23S;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INFECTION CONTROL; JAPAN; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRAIN DIFFERENCE;

ADOLESCENT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; NITROREDUCTASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RNA, RIBOSOMAL, 23S;

ANIMALIA; BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 0036162237     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.2.649-653.2002     Document Type: Article

References (34)

1. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin: Influence on treatment outcome
2. Feature and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999)
3. Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori
4. Insertion of mini-IS 605 and deletion of adjacent sequences in the nitroreductase (rdxA) gene cause metronidazole resistance in Helicobacter pylori NCTC11637
5. Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children
6. Mutation in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin
7. Use of an amplified-fragment length polymorphism technique to fingerprint and differentiate isolates of Helicobacter pylori
8. Drug therapy for Helicobacter pylori infection: Problems and pitfalls
9. Metronidazole resistance in Helicobacter pylori is due to null mutation in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase
10. Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy
11. Antibiotic resistance in Helicobacter pylori: Implications for therapy
12. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: A randomized, controlled study
13. Unique features of Helicobacter pylori disease in children
14. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer
15. Single and multiple strain colonization in patients with Helicobacter pylori-associated gastritis: Detection by macrorestriction DNA analysis
16. Treatment after failure: The problem of "non-responders."
17. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children
18. Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children
19. Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children
20. Successful development of air-dried microplates (HP-Plates) for susceptibility testing against Helicobacter pylori isolates
21. The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
22. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH I study
23. Helicobacter pylori infection in a pediatric population: In vitro susceptibilities to omeprazole and eight antimicrobial agents
24. Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance
25. Simultaneous colonisation of Helicobacter pylori with and without mutations in the 23S rRNA gene in patients with no history of clarithromycin exposure
26. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori
27. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil
28. Comparative evaluation of E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents
29. Molecular typing of Helicobacter pylori isolates from a multicenter U.S. clinical trial by ureC restriction fragment length polymorphism
30. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori
31. Stable amoxicillin resistance in Helicobacter pylori
32. Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance
33. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori